Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesBenign neoplasms, except benign neuroendocrine tumorsICD-10-CM d11-benign-neoplasm-major-salivary-glands
    Ask Trek AI about this page

    ICD-10-CM Code For Benign Neoplasm Of Major Salivary Glands: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group D11 includes benign neoplasms of the major salivary glands such as pleomorphic adenoma and other nonmalignant tumors of the parotid, submandibular, and sublingual glands. These ICD-10-CM diagnosis codes are used to document clinical encounters involving diagnosis, evaluation, surgical management, or surveillance of benign salivary gland tumors, capturing anatomical site and any related complications. Accurate coding within the ICD-10-CM D11 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Benign Neoplasm Of Major Salivary Glands: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM D11: Benign Neoplasm Of Major Salivary Glands Overview

    This group includes benign tumors arising in the major salivary glands, primarily the parotid, submandibular, and sublingual glands. These diagnoses target the head and neck region and encompass nonmalignant neoplastic growths of salivary tissue. Accurate coding is important for clinical documentation, appropriate claim adjudication, and reimbursement determination.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when a clinician documents a benign salivary gland neoplasm as the reason for the encounter, procedure, or treatment. Codes in this group are also appropriate for preoperative diagnosis, postoperative follow-up, and surveillance of known benign salivary gland tumors.

    ICD-10-CM Codes

    3 rows

    ICD-10-CM CodeDescription
    D11.0Benign neoplasm of parotid gland
    D11.7Benign neoplasm of other major salivary glands
    D11.9Benign neoplasm of major salivary gland, unspecified

    DRG Codes

    6 rows

    DRG CodeDescription
    011Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with MCC
    012Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with CC
    013Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy without CC/MCC
    154Other Ear, Nose, Mouth and Throat Diagnoses with MCC
    155Other Ear, Nose, Mouth and Throat Diagnoses with CC
    156Other Ear, Nose, Mouth and Throat Diagnoses without CC/MCC

    Typical Clinical Scenarios

    • A 45-year-old woman presents to otolaryngology clinic with a slowly enlarging, painless firm mass in the region of the parotid gland noticed over several months. Imaging (ultrasound and MRI) demonstrates a well-circumscribed superficial parotid tumor without facial nerve involvement; fine-needle aspiration suggests a benign epithelial neoplasm. A benign neoplasm code for the major salivary gland is assigned when the lesion is localized to the parotid and histology/biopsy supports a nonmalignant tumor. Typical codes: D11.0

    • A 62-year-old man with long-standing smoking history reports a progressively enlarging, asymptomatic submandibular swelling found incidentally on dental exam; physical exam and ultrasound show a discrete mass in the submandibular gland. Excisional biopsy confirms a benign salivary gland neoplasm arising in the submandibular gland, and the benign salivary gland neoplasm code specific to that gland is used to document the diagnosis. Typical codes: D11.7

    • A 29-year-old patient presents to primary care with a small, mobile lump under the cheek near the minor salivary tissue that had been present for years but recently increased in size and caused local discomfort. Clinical evaluation and pathology report identify a benign neoplasm of a salivary gland site not otherwise specified on initial documentation; when the exact major gland (parotid or submandibular) is not specified in the record, a general benign salivary gland neoplasm code is assigned pending or in absence of more specific localization. Typical codes: D11.9}

    Related Codes

    D10-BENIGN-NEOPLASM-OF-MOUTH-AND-PHARYNX

    ICD-10-CM Code For Benign Neoplasm Of Mouth And Pharynx: Group Overview

    D12-BENIGN-NEOPLASM-COLON-RECTUM-ANUS

    ICD-10-CM Code For Benign Neoplasm Of Colon Rectum Anus And Anal Canal: Group Overview

    D13-BENIGN-NEOPLASM-OTHER-DIGESTIVE

    ICD-10-CM Code For Benign Neoplasm Of Other And Ill-Defined Parts Of Digestive System: Group Overview

    D14-BENIGN-MIDDLE-EAR-AND-RESPIRATORY-NEOPLASMS

    ICD-10-CM Code For Benign Neoplasm Of Middle Ear And Respiratory System: Group Overview

    D15-BENIGN-NEOPLASM-INTRATHORACIC-ORGANS

    ICD-10-CM Code For Benign Neoplasm Of Other And Unspecified Intrathoracic Organs: Group Overview

    D16-BENIGN-NEOPLASM-OF-BONE

    ICD-10-CM Code For Benign Neoplasm Of Bone And Articular Cartilage: Group Overview

    D17-BENIGN-LIPOMATOUS-NEOPLASM

    ICD-10-CM Code For Benign Lipomatous Neoplasm: Group Overview

    D18-HEMANGIOMA-AND-LYMPHANGIOMA

    ICD-10-CM Code For Hemangioma And Lymphangioma, Any Site: Group Overview

    D19-BENIGN-MESOTHELIAL-NEOPLASMS

    ICD-10-CM Code For Benign Neoplasm Of Mesothelial Tissue: Group Overview

    D20-BENIGN-SOFT-TISSUE-RETROPERITONEUM

    ICD-10-CM Code For Benign Neoplasm Of Soft Tissue Of Retroperitoneum And Peritoneum: Group Overview

    Showing 1–10 of 26

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.